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dihydrochloride (DAP), a potent inhibitor of ODC, on rat
Enzymes involved in the biosynthesis of the polyamines are two-stage urinary bladder carcinogenesis initiated with considered as targets in this respect (3) . Ornithine decarb-
N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN). In experi-
oxylase (ODC) is a key regulatory enzyme in the biosynthesis ment 1 (36 weeks), 6-week-old F344 male rats were adminisof polyamines, which are essential for cell growth and differentered 0.05% BBN in drinking water for 4 weeks and then tiation (4) . Accumulating evidence indicates that ODC overdivided into four groups. Animals of groups 1 and 2 expression may play a critical role in neoplastic transformation received basal diet and drinking water supplemented with (5) and ODC activity has been shown to be moderately elevated or without DAP (2 g/l). Groups 3 and 4 were given diet in urothelial carcinomas induced experimentally in rodents by containing 5% sodium L-ascorbate (NaAsA), a typical chemical carcinogens (6) and in digestive tract carcinomas in urinary bladder tumor promoter, and drinking water humans (7) . An increase in ODC activity is characteristically with or without DAP. Administration of DAP to group 1 associated with rapid tissue growth, particularly in the mammasignificantly reduced tumor size, multiplicity and incidence, lian fetus (8) . Application of ODC inhibitors such as various particularly of papillomas, when compared with group 2 3,6-carbon diamine analogs of putrescine, the initial product values. DAP together with NaAsA (group 3) also decreased in the polyamine biosynthesis pathway, has been shown to tumor size relative to the group 4 case. To determine the decrease tissue growth and ODC activity in vitro (9) . One of effects of DAP on the early stages of bladder carcinogenesis these inhibitors, 1,3-diaminopropane (DAP), has the potential and its mechanisms, a similar protocol was conducted for clinical application against neoplasia (10) . Another ODC (experiment 2) with death after 20 weeks. DAP treatment inhibitor, α-difluoromethylornithine (DFMO), has been found caused complete inhibition (0% incidence) of papillary to inhibit rat urinary bladder carcinogenesis in vivo (11) and and/or nodular hyperplasia in group 1 but was without is widely used due to its potent inhibition of growth of most influence in group 3, as compared with the respective animal cells (12) . controls. Moreover, the ODC activity, bromodeoxyuridine
Inhibitory effects of DAP on tumor promotion have been labeling indices and mRNA expression levels of cyclin D1 studied recently in some experimental animal carcinogenesis in the urinary bladder mucosa, determined by northern protocols. Administration of DAP together with gastric tumor blotting, were markedly lower in group 1 than in group 2, promoters, such as bombesin, tyrosine methyl ester or sodium but values were comparable for both groups administered chloride, attenuated their enhancement of carcinogenesis and NaAsA. Assessment of mRNA expression levels of the decreased the ODC activity and the bromodeoxyuridine (BrdU) angiogenic vascular endothelial growth factor suggested no labeling indices of the gastric mucosa in rats (13) (14) (15) . It also involvement in the inhibitory effects of DAP on urinary inhibited the promoting effects of bombesin (16) and vasoactive bladder carcinogenesis. The results indicate that inhibition intestinal peptide enhancement (17) of azoxymethane-induced of ODC could reduce urinary bladder carcinogenesis in rat colon carcinogenesis. However, effects on rat two-stage rats, particularly in the early stages, through antiproliferatbladder carcinogenesis and its underlying mechanisms in vivo ive mechanisms.
have yet to be established. Fukushima et al. (18) have reported that sodium L-ascorbate (NaAsA) enhances the development of bladder tumors in male rats when fed after administration of the carcinogen N-butyl-application of NaCl, a gastric tumor promoter, to rats was recently shown to induce ODC and SAT activities with a peak after 5-7 h (22). Also, ODC overexpression is apparently intimately involved in tumor promotion in mouse skin (23). To test the possibility that suppression of ODC might inhibit carcinogenesis in the bladder, the post-initiation effects of DAP with and without NaAsA were assessed in the present experiment.
Studies in vitro and in vivo have shown that ODC inhibition may be a way to control cell proliferation (24) and specific inhibitors can prevent neoplastic development associated with water; , 2 g/l DAP in drinking water; u, no treatment; , 5% NaAsA in antiproliferative potential in a number of organs (3) . In animal diet ϩ 2 g/l DAP in drinking water; , 5% NaAsA in diet; U, urinalysis models, DAP may inhibit cancer while reducing proliferation and pH measurement; ., killing.
(13-17). Homma et al. (25) earlier showed that the inhibitory characteristics of the ODC inhibitor DFMO on rat urinary After evaluation of the pH value of each sample (model F-15 pH meter; bladder carcinogenesis were accompanied by a remarkable Horiba, Kyoto, Japan), all samples were kept frozen at -80°C until the urinary inhibition of cell proliferation. Induction of cell proliferation electrolyte levels of Na, K, Cl, Ca and P (710 electrolyte analyzer; Hitachi, and inhibition of apoptosis are suggested to be one mechanism Tokyo, Japan) and the urinary protein and creatinine levels (ARC 950; Aloka, Tokyo, Japan) were determined.
underlying tumor promotion (26) , with significant roles for growth factors (27,28). 
BrdU staining and evaluation of labeling indices. Immunohistochemical Animals and diet
staining for BrdU was performed using an avidin-biotin complex (ABC) kit A total of 157 male F344 rats (Charles River Inc., Hino, Japan), 5 weeks old in combination with an anti-BrdU monoclonal antibody, according to the at commencement, were used. The animals were housed four or five to a manufacturer's instructions (code no. M0744; Dako A/S, Denmark). Tissue plastic cage, with wood chips for bedding, and were given water and MF sections were deparaffinized with xylene, hydrated through a graded ethanol powdered diet (Oriental Yeast Co., Tokyo, Japan) ad libitum. They were kept series and incubated with 0.3% hydrogen peroxide for 30 min to block for a 1 week acclimation period before the start of the experiments. The endogenous peroxidase activity. They were then incubated with 10% normal animal room was controlled at a temperature of 22 Ϯ 1°C, at 55 Ϯ 5% horse serum at room temperature for 30 min to block background staining humidity and with a 12 h/12 h light/dark cycle.
and overnight at 4°C with BrdU diluted 1:1000 in Tris-buffered saline (TBS).
Chemicals
After exposure for 30 min at room temperature to biotinylated horse antimouse IgG (Vector Laboratories, Burlingame, CA), sections were incubated BBN was obtained from Tokyo Kasei Co. (Tokyo, Japan). DAP (Sigma, with avidin-biotin complex at 1:25 dilution. Each step was followed by St Louis, MO) and NaAsA were from Wako Industries Co. (Osaka, Japan).
washing with TBS. Peroxidase activity was visualized by treatment with a Experiment I 0.02% solution of diaminobenzidine tetrahydrochloride containing 0.05% Two-stage bladder carcinogenesis study. A total of 67 rats were divided into hydrogen peroxide. Then nuclei were counterstained with hematoxylin. The four groups taking body weights into account, in order to decrease the standard labeling indices were evaluated as percentages of cells incorporating BrdU errors in each group. All animals were given 0.05% BBN in drinking water into S phase DNA in representative PN hyperplasias and tumors (papillomas continuously for 4 weeks as the initiation step. Two days after the end of and carcinomas). BBN treatment, the rats were treated as follows until the end of the experiment
In situ detection of apoptosis. To assess possible relationships between at week 36: group 1 (17 rats) received the normal basal diet and DAP (2 g/l) metabolic stress caused by DAP or NaAsA and programmed cell death in in their drinking water; group 2 (17 rats) received the basal diet and tap water tumors, direct immunoperoxidase detection of digoxigenin-labeled genomic without supplement as BBN positive controls; group 3 (18 rats) received 5% DNA fragmentation in situ was performed according to the manufacturer's NaAsA, mixed into the MF basal diet, and were concurrently administered instructions by the NEL technique (transfer of biotinylated nucleotide to the DAP (2 g/l) in their drinking water; group 4 (15 rats) received 5% NaAsA 3Ј-OH end), using an ApopTag in situ apoptosis kit (catalog no. S7100; Oncor, mixed with the basal diet and tap water. Animals were observed daily to Gaithersburg, MD). Apoptotic indices were generated by counting NEL assess general health and body weights and food and water consumption were apoptotic bodies in PN hyperplasias and tumors, expressed as percentage measured weekly (experimental design given in Figure 1 ). One hour prior to values. death, all animals were injected i.p. with 100 mg/kg body wt BrdU (Sigma, Experiment II St Louis, MO) to measure DNA synthesis in terms of incorporation of label. Analysis of urine. Fresh urine samples were collected from at least 10 animals Two-stage bladder carcinogenesis study. The same two-stage bladder carcinogenesis protocol as in experiment I with an experimental period of 20 weeks in each group by forced urination in the morning 1 day before being killed.
was carried out to evaluate the effects of DAP on the early stages of bladder (upstream) and 5Ј-CAGGACCTCCTTCTGCACAC-3Ј (downstream) obtained from the genebank of the National Centre for Biotechnology Information carcinogenesis. A total of 80 rats were divided into the same four groups (20 per group). An additional group of 10 non-treated rats were kept separately home page. The primer sequences were assessed using the software GENETEX MAC v.8.0. The resultant PCR products were inserted into plasmid pCRas a control group for collection of urinary bladder mucosa for northern blotting analysis. Animal killing, bladder preparation, determination of tumor Script SK(ϩ) using a pCR-Script SK(ϩ) cloning kit (Stratagene, La Jolla, CA). cDNA clones containing the template sequence for sense and antisense incidences and multiplicities, histological evaluation and immunohistochemical analysis for BrdU labeling indices were performed as described above.
RNA probe synthesis were propagated and plasmid DNA was recovered with a plasmid extraction kit (Plasmid Midi; Qiagen, Chatsworth, CA). The sense Tissue preparation for ODC and SAT activities, polyamine levels and northern probes were generated as 1.0 kb HindIII-HindIII fragments and RNA synthesis blotting. Whole urinary bladders of 15 randomly chosen rats from each group was with T3 RNA polymerase. The rat Cdk4 cDNA was a 1.2 kb EcoRIand from the control non-treated group were opened longitudinally and EcoRI fragment (35), the VEGF cDNA was a 1.8 kb SalI-SalI fragment (36) incubated in phosphate-buffered saline (pH 7) containing 25 mM EDTA for and the GAPDH DNA was a 1.3 kb PstI-PstI fragment (37). 10 min at 37°C. The urinary bladder mucosae were scraped off with sterilized clean slide glasses and kept frozen at -80°C until assayed for ODC and SAT Statistical analysis activities and total polyamine levels and northern blot analysis.
Significances of differences between group mean values were analyzed using the paired two-tailed Student's t-test and values for bladder lesion incidence ODC and SAT activities and polyamine assays. The activities of ODC and were analyzed using the χ 2 or exact probability test (StatView v.4.5; Abacus SAT were measured by a radiometric technique from release of 14 CO 2 from Concepts). L-[1-14 C]ornithine, as described previously (34) . Briefly, frozen pieces of urinary bladder epithelium from 10 samples were suspended separately in 0.5 ml of 50 mM Tris (pH 7.5) containing 0.25 M sucrose and disrupted with NaAsA treatment as compared with group 2 and the concentraNorthern blot hybridization. For RNA hybridization, 10 µg samples of total tion of K was lowered. DAP treatment was without significant RNA were denatured by incubation with 1 mol/l deionized glyoxal and effects on ion concentrations except that Cl in group 3 was 50% dimethylsulfoxide at 50°C for 1 h and electrophoresed on 1% agarose increased compared with groups 2 and 4. gels at 50 V. The 28S and 18S rRNAs in gels were stained with ethidium bromide to demonstrate the integrity of applied RNA and to verify that the Urinary bladder lesions. Grossly, papillary tumors were seen same amounts of RNA were applied to each lane. RNAs in the gels were in the urinary bladders of all groups. The degrees of lesion then transferred to nylon membranes (GeneScreen Plus; EI du Pont de development in rats receiving NaAsA (groups 3 and 4) were treated group showed significantly less proliferation than in Evaluation of apoptosis in bladder tumors. No significant differences were detected in the percentages of apoptotic cells the BBN control group. Labeling indices for bladder tumors in animals treated with DAP and NaAsA also showed a slight in the papillomas or carcinomas found in groups 1 and 2. The apoptotic indices for PN hyperplasias were low, without decrease as compared with their counterparts in the NaAsAtreated group, but the difference was not statistically significant.
variation among the groups. Papillomas and carcinomas had with BBN followed by DAP and/or NaAsA (experiment II). *Significantly different versus group 2 (P Ͻ 0.001). , G1; , G2; , G3; , G4.
high values, particularly the former, possibly due to increasing proliferation during progression into cancer. In the NaAsA ϩ rat were similar. No tumors (papillomas or carcinomas) DAP-treated group 3, a significant increase in the percentage developed in any group. At the histological level, the urinary of apoptotic cells in papillomas and carcinomas was found as bladder epithelia of the rats in groups 3 and 4 were mostly compared with the group 4 values (Figure 4) . hyperplastic (simple hyperplasia).
Experiment II
BrdU labeling indices. Percentages of BrdU-labeled cells were evaluated in different parts of the normal mucosa, areas of Two stage bladder carcinogenesis. Clinical observation did not reveal any abnormalities among the groups and no deaths simple hyperplasia and in the PN hyperplastic lesions ( Figure  5 ). The labeling index of the normal mucosa of group 1 occurred during this experiment. Administration of DAP with or without NaAsA for 16 weeks resulted in no obvious (0.45%) was significantly decreased by~45% as compared with the group 2 value (0.82%). However, the values for differences in body weights. Also, the absolute and relative weights of the bladder, liver and kidney were similar in all groups 3 and 4 were similar (1.5 and 1.45%, respectively). In areas of simple hyperplasia, DAP treatment in group 1 was groups. Water intake and food consumption were not found to be changed (data not shown).
associated with a significant lowering of the BrdU index to a third of that for the BBN control. No differences were observed Urinary bladder lesions. Grossly, minute nodular lesions between groups 3 and 4, values being 3.6 and 2.6% for simple (ഛ2 mm) had developed in the bladder mucosa only in rats hyperplasia and 5.3 and 4.5%, respectively, for PN hyperplasia. receiving BBN ϩ NaAsA (groups 3 and 4) and those given BBN alone (group 2). Histopathological findings in the urinary ODC and SAT activities and polyamine levels in the bladder mucosa. Table V summarizes data for ODC and SAT activities bladders are summarized in Table IV . DAP administration (group 1) caused complete inhibition (0% incidence) of formaand Table VI shows values for the polyamines spermidine, spermine and N1-AcSPD in the bladder mucosa. ODC values tion of epithelial lesions in the urinary bladder, in contrast to the 60% incidence observed for group 2. The incidences of in group 1 were significantly lower than in group 2. Activities in groups 3 and 4 were elevated by NaAsA treatment. No PN lesions were 100% in both groups 3 and 4 and numbers/ variation in SAT values was evident. The levels of spermine expression of Cdk4 was slightly decreased by DAP treatment and spermidine were significantly higher in the NaAsA-treated in group 1 as compared with group 2, but VEGF mRNA groups over the other two groups, but did not differ between expression showed no comparable differences between groups groups 1 and 2 or between groups 3 and 4 at the time of death.
1 and 2 or groups 3 and 4. Northern blot analysis. Northern blotting data for mRNA expression of cyclin D1, Cdk4 and VEGF processed by image Discussion analyzer and compared with expression of GAPDH are shown
In the present study administration of DAP for 32 weeks in Figures 6 and 7 . Among the tested mRNA levels, the values (experiment 1) exerted significant inhibitory effects on BBN of cyclin D1 were markedly reduced by the DAP treatment in urinary bladder carcinogenesis. Interestingly, the administration group 1, compared with group 2. Although the mRNA levels of DAP alone for 16 weeks resulted in complete inhibition of of cyclin D1 and Cdk4 expressed in the groups treated with development of early stage lesions in experiment 2. DAP was NaAsA were higher than those of the other two groups, they also very effective at inhibiting cell proliferation, as indicated did not differ between groups 3 and 4. DAP decreased the cyclin D1 mRNA levels to normal control values. mRNA by the significant decrease in the BrdU labeling index in line
In previous studies, inhibition of VEGF, a potent angiogenic factor and mediator of vascular permeability, was found to block tumor neovascularization with consequent inhibition of both primary tumor growth and micrometastasis when inhibitors were administered at the time of tumor inoculation (46, 47) . In the present study, the marked inhibitory effects on the early stages of bladder carcinogenesis by DAP were not linked to any change in VEGF mRNA levels.
Administration of DAP together with NaAsA did not show clear inhibitory effects on tumor development, although late lesion size was significantly reduced, probably due to increased apoptosis. Also, an unequivocal influence on the other parameters investigated was not apparent. The significant increases in DNA synthesis and ODC activity were in line with promotion of tumor development by NaAsA, and a close relationship between tumor-promoting capacity of chemicals and induction of ODC and cell proliferation has been reported (48) . Since there were no significant differences in percentages of apoptotic cells between tumors in groups 1 and 2, the inhibitory effects with aspirin in inducing apoptosis in colonic lesions in rats. In previous studies, both increased apoptosis and/or decreased cell proliferation have been proposed as mechanisms for the with the drop in ODC activity and down-regulation of the cell cycle regulator cyclin D1.
chemopreventive activities of many agents (50,51). It has been demonstrated (52) that non-genotoxic carcinogens may Moshier et al. (38) concluded that genetic events affecting cell proliferation, polyamine metabolism and/or growth regulatdifferentially alter molecular pathways involving p53, bcl-2 and bax. Some cell lines show resistance to the antiproliferative ing mechanisms are required for tumorigenesis to occur in vivo. Increased numbers of cycling cells in a target organ would be effects of ODC inhibitors in vitro. Pegg et al. (53) postulated that this resistance appears to be mediated by the presence of expected to increase susceptibility to tumor induction (39) . Cyclins are positive regulators of cell cycle progression. They elevated levels of ODC and, in some cases, this overproduction was due to a massive increase in ODC mRNA or an increased function by forming complexes with and activating a class of protein kinases, CdKs, which are essential for cell cycle rate of transcription of the gene (54). This might explain the relative increase in ODC activity in group 3 over group 4 in transition (40) . Cyclin D1 binds to and activates its major catalytic subunits, Cdk4 and Cdk6, which regulate G 1 phase experiment 2 found here. On the other hand, polyamine metabolism could be affected by oncogene expression, as progression and the G 1 /S transition through phosphorylation of the retinoblastoma (Rb) tumor suppressor protein (41). The exemplified by the observation that N-myc-transfected rat fibroblasts do not exhibit elevated ODC activity but rather present investigation shows for the first time a correlation between ODC inhibition and modulation of the expression of accumulate polyamines by increasing their transport into the cell (55). the cell cycle regulator cyclin D1 in bladder carcinogenesis. DAP after BBN treatment thus decreased cyclin D1 mRNA This present study has demonstrated a particularly strong effect of DAP on the development of PN hyperplasia after levels, with a slight reduction in Cdk4, as compared with the BBN alone group. Cyclin D1 is a marker of cell proliferation BBN initiation alone. Soler et al. (56) also showed complete suppresion of papillomas in mouse skin by DFMO. The in normal and dysplastic epithelia of the oral cavity (42) and Weinstein (43) has postulated that increased expression can availability of polyamines from other endogenous sources, and also an exogenous supply (57), could be the reason for the enhance gene amplification and cell transformation, antisense blocking of its action resulting in reversion of malignant cells.
induction of a few tumors after prolonged administration of DAP in the first experiment. Putrescine can be mobilized by Lee et al. (32) hypothesized that PN hyperplasias with extensive cyclin D1 overexpression are more likely to progress to interconversion reactions in one tissue and utilized in another, with the circulation functioning as a transport system (58). advanced lesions, such as papillomas or carcinomas, in rat bladder carcinogenesis, probably related to acquisition of Exogenous polyamines from the pool of acetylated forms at the cellular level or from the diet or intestinal bacteria may autonomous growth properties. This is consistent with the results of Boyle et al. (44) , who showed that degradation of stimulate cell proliferation and growth (59) and depletion of cellular polyamines can elicit compensatory uptake of cyclin D1, which leads to arrest of cells in the G 1 phase of the cell cycle, is an intermediate marker for effective retinoidextracellular polyamines (60) . Spermine turnover occurs in principle through the consecutmediated cancer chemoprevention in the aerodigestive tract. Inhibitory effects were also shown to be accompanied by a ive action of SAT and FAD-dependent polyamine oxidase (61).
No changes in polyamine levels or SAT activities between reduction in the Cdk4 and cyclin E proteins and temporally associated with decreased levels of hyperphosphorylated Rb groups were detected at the time of death, but the levels of N1-AcSPD, an acetylated derivative of spermine and spermidprotein without any significant change in c-myc, p21 or p27 expression (45) .
ine, were found to be decreased by DAP treatment. Recently, those with tumors containing low levels of the derivative (63 in previous experimental animal studies (13) (14) (15) (16) (17) 
